Evidence map›Paper›PMID 34988461›Full record

ArticleAdvances in pharmacological and pharmaceutical sciences2021

Milad Jeshan, Fatemeh Yousefbeyk, Hiva Rahmati, Amir Hosein Shoormeij, Mitra Rezazadeh, Ehsan Zamani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in pharmacological and pharmaceutical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. An Ethnopharmacological Survey on Medicinally Important Plants of Genus Salvia.Combinatorial chemistry & high throughput screening · 2025
    Review
  3. Natural Compounds ofBiomedicines · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Milad JeshanStudent Research Committee, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0002-4117-0431
Fatemeh YousefbeykDepartment of Pharmacognosy, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0002-2793-6445
Hiva RahmatiStudent Research Committee, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0002-0252-572X
Amir Hosein ShoormeijStudent Research Committee, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
Mitra RezazadehLaboratory of Pathology, Imam Khomeini Hospital, Jiroft University of Medical Sciences, Jiroft, Iran.
Ehsan ZamaniDepartment of Pharmacology and Toxicology, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.ORCID https://orcid.org/0000-0003-2033-0683
Guilan University of Medical Sciences · IRUniversity of Jiroft · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial oxidative damage is a crucial factor in the pathogenesis of diabetic nephropathy (DN), which is among the most prevalent problems of diabetes, and there hasn't been an effective treatment for DN yet. This study planned to investigate the effects of

Identifiers

PMID34988461
PMCPMC8720605
OpenAlexW4200163373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.